Thermo Fisher Scientific (Canada)

Recent papers from Thermo Fisher Scientific (Canada)

1. Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United StatesAdvances in Therapy · 2026
2. Comparative efficacy and safety of acoramidis versus tafamidis in patients with transthyretin amyloid cardiomyopathy: an anchored matching-adjusted indirect comparisonEuropean Heart Journal Open · 2026
3. A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy AdultsPharmaceuticals · 2026
4. Characterization of pediatric patients receiving erythropoiesis-stimulating agents for management of anemia of chronic kidney disease in the UK and US: a feasibility assessment using retrospective chart reviewBMC Nephrology · 2026
5. Data-Independent Acquisition for Improved Compound Annotation in MALDI MS ImagingJournal of the American Society for Mass Spectrometry · 2026
6. Enhanced δD measurability in low-abundance compound-specific isotope analysis using controlled isotope dilution with mass-balance correctionOrganic Geochemistry · 2026
7. Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysisDermatology and Therapy · 2026
8. Single-Ion Imaging Native Mass Spectrometry: Unraveling the Structural Features and Dissociation Energetics of Macromolecular AssembliesJournal of the American Society for Mass Spectrometry · 2026
9. Predictors of real-world progression-free survival (rwPFS) in patients (pts) with epithelial ovarian cancer (EOC) treated with first-line maintenance (1LM) niraparib (nir): Post hoc analysis of the 1NSPIRE chart review study.Journal of Clinical Oncology · 2026
10. Comparative efficacy of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs standard of care in patients with relapsed/refractory multiple myeloma (RRMM).Journal of Clinical Oncology · 2026
11. Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE studyWorld Allergy Organization Journal · 2026
12. C103-14 Predicting Long-Term Survival Benefit of Nerandomilast in Patients With Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine · 2026
13. Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic PancreatitisDigestive Diseases and Sciences · 2026
14. Patient and clinician preferences for adjuvant treatment following surgical resection in early-stage non-small cell lung cancer: A multi-country discrete choice experimentLung Cancer · 2026
15. Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn's disease: results from the EVOLVE Expansion study.2026
16. OBC: Optimized Batch Correction with Dual-level Quality Control for Scalable Proteomics and MetabolomicsGenomics Proteomics & Bioinformatics · 2026
17. Toward Molecular Forensics of Agrochemicals with Orbitrap IRMS: Isotopic Fingerprints of Imidacloprid Sources and Elucidating HydrolysisJournal of the American Society for Mass Spectrometry · 2026
18. Expanding the Global Map of Protein Post-Translational Modifications With Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass SpectrometerMolecular & Cellular Proteomics · 2026
19. Abstract 7705: Simultaneous quantitation and discovery of cancer-related proteins in plasma using a fast, high-resolution accurate mass spectrometry-based assay provides insight into precision oncology and drug discoveryCancer Research · 2026
20. Evolution of patient characteristics and outcomes in ATTR-CM clinical trials: A systematic reviewProgress in Cardiovascular Diseases · 2026